Jiangsu Hengrui Medicine Co., Ltd. (600276) Moves Up 3.59% on Mar 15

March 15, 2018 - By Linda Rogers

Shares of Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276) last traded at 82.78, representing a move of 3.59%, or 2.87 per share, on volume of 8.47 million shares. After opening the trading day at 79.57, shares of Jiangsu Hengrui Medicine Co., Ltd. traded in a close range. Jiangsu Hengrui Medicine Co., Ltd. currently has a total float of 2.83 billion shares and on average sees 9.91M shares exchange hands each day. The stock now has a 52-week low of 42.92 and high of 83.

SSE: An Asian Economy Pride

Aside from being the world’s largest country in terms of population, China is also the largest economy in Asia, placing it next to the US worldwide. Behind this success is the nation’s leading stock exchange, the Shanghai Stock Exchange (SSE).

Chinese Equity Market

With over 1,000 companies listed on it and a market capitalization of $3.50 trillion as of February, the SSE is the second largest stock exchange in Asia and the fifth in the world. Jiangsu Hengrui Medicine Co., Ltd. and others prefer to work at this reliable market. As a non-profit organization, it is operated by the China Securities Regulatory Commission (CSRC).

While the SSE had already been established in 1866, it had to shut down in 1941 due to the Japanese occupation in Shanghai. On December 19, 1990, after decades of setback, the SSE finally had its major comeback with an official relaunch of operations.

All SSE stocks are tracked on the SSE Composite Index, which was launched officially on July 15, 1991. For a clearer and more accurate representation of the Chinese equity market, it features three main sub-indices: the SSE 380, the SSE 180, and the SSE 50. The SSE 380 is made up of the 380 most active stocks on the SSE; the SSE 180 is made up of the 180 most active stocks; and the SSE 50 is made up of the 50 most active stocks. In order for a stock to qualify in the SSE 50, it must first be included in both the SSE 380 and the SSE 180.

The SSE Composite Index is a market-capitalization-weighted index, which means that all of its components are weighted using the Paasche weighted composite price index formula. Its base date and base value is December 19, 1990 and 100, respectively.

In December 1990, the SSE Composite Index had hit its all-time low of 99.98 and in October 2007, its all-time high of 6,092.06. Being the part of SSE index gives new options for Jiangsu Hengrui Medicine Co., Ltd. stocks.

Trading in China

The pre-market session on the SSE lasts from 9:15 a.m. until 9:25 a.m. while the regular session lasts from 9:30 a.m. until 3:00 p.m. In between the regular session is a two-hour break that lasts from 11:31 a.m. until 1:29 p.m.

All SSE stocks are classified into two categories of shares: A shares and B shares. The former type of shares is traded in Yuan while the latter is traded in US dollar (USD). Only domestic traders were allowed to trade A shares in the past. International traders were only allowed to trade B shares. However, in 2002, international traders had finally been allowed to trade A shares and B shares alike like domestic traders. As a result, the Chinese economy had bloomed immensely and still continues a rapid economic growth today. Companies, like Jiangsu Hengrui Medicine Co., Ltd. also grow with the economy.

It is ideal to invest on SSE stocks today given the fast-paced growth of what is already the second biggest economy in the world. By doing so, investors can expect high returns from the Chinese equity market regardless of whether investments are short-term or long-term.

More notable recent Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276) news were published by: Businesswire.com which released: “Jiangsu Hengrui Medicine and Arcutis Announce a Development and …” on January 05, 2018, also Globenewswire.com with their article: “TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement …” published on January 08, 2018, Businesswire.com published: “Incyte Announces Global License Agreement with Jiangsu Hengrui Medicine for …” on September 02, 2015. More interesting news about Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276) were released by: Prnewswire.com and their article: “Jiangsu Hengrui Medicine Enters into Agreement with The University of Texas MD …” published on May 03, 2016 as well as Prnewswire.com‘s news article titled: “Jiangsu Hengrui Medicine Announce Collaboration with Albert Einstein College …” with publication date: April 25, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.